In the US, Pramipexole (pramipexole systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease, Periodic Limb Movement Disorder, Restless Legs Syndrome and Tardive Dyskinesia.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Dopamine agonist

Treatment of Parkinson's disease

Chemical Name

2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N⁶-propyl-

Foreign Names

  • Pramipexolum (Latin)
  • Pramipexol (German)
  • Pramipexole (French)
  • Pramipexol (Spanish)

Generic Names

  • Pramipexole (OS: DCF, USAN, BAN)
  • SUD 919 CL 24 (IS)
  • U 98528 E (IS: Upjohn)
  • Pramipexole Hydrochloride (OS: BANM, USAN)
  • PNU 98528 (IS: PharmaciaUpjoh)
  • SND 919 Cl 2Y (IS: Boehringer Ingelheim)
  • Pramipexole Dihydrochloride Monohydrate (PH: BP 2011)
  • Pramipexole dihydrochloride monohydrate (PH: Ph. Eur. 7)
  • Pramipexoli dihydrochloridum monohydricum (PH: Ph. Eur. 7)

Brand Names

International Drug Name Search


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.